20 Live Notices for عوامل الوكلاء المثبطة للمناعة
Showing 1 to 20
Lp Containing Adalimumab 2025
02 Jun 2025
03 Jul 2025Un Motol - Tilldrakizumab 200 Mg
Delivery Of Anti -Cancer Agents, Funds Immunosuppressive, Immunoglobulin, Divided Into 14 Parts. Mark Of The Case: Zp.26.36.2025.Kch
Drug Supply - The Active Substance Golimumab - Atc L04Ab06
Dns - Filgotinib
Immunosuppressant - Inhibitor To The Pagcetacoplan I. Complement I.
Immunosuppressant - Inhibitor To The Pagcetacoplan I. Complement I.
Immunosuppressant - Inhibitor To The Pagcetacoplan I. Complement I.
Lp Containing Anagrelide 2025
Purchase Of Medicines Haridi Mavodҳoy Doruvorӣ
Drug Supply - The Active Substance Ofatumumab - Atc L04Ag12
Drug Supply - Active Substance Certolizumab Pegol - Atc L04Ab05
Drug Supplies - The Active Substance Natalizumab - Atc L04Ag03
Delivery Of Medicinal Products To Drug Programs, Various Medicines, Medical Devices And Various Products
Environmentally Friendly Supply Of Biological Human Medicines With Biosimilars For Public Health Centres In Valencia
Environmentally Friendly Supply Of Biological Human Medicines With Biosimilars For Public Health Centres In Valencia
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Abatacept (Atc Code: L04Aa24).
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Certolizumab Pegol (Atc Code: L04Ab05).
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Tocilizumab (Atc Code: L04Ac07).
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products With The Active Ingredient Fingolimod (Atc Code: L04Aa27).
Tenders by Country